Resources

877 Resources for

biotech

Subscribe to this listing via:
RSS
Email

BNET Resources

Genentech?s New ADC Platform Has Much Potential, but Is Yet to Be Tested on Humans: Ohad Hammer submits: On June 18th, Seattle Genetics SGEN announced it had received a milestone payment from Genentech DNA after the latter filed an IND Investigational New Drug application for an antibody-drug conjugate [ADC] powered by Seattle Genetics’ technology. Intriguingly, there was no additional data about the new agent, nor...; Tags: Biotech, Healthcare, Genentech Inc., ImmunoGen Inc., Seattle Genetics Inc.; External links 2008-08-06
Be Selective with Medical Device Companies: Zacks.com submits: With earnings season beginning to wind down in the medical devices and supplies industry, we figured it would be a good time to check in with Zacks senior analyst Tom Park. We were looking to see if there are any attractive buys among his coverage....; Tags: Healthcare, Biotech, Immucor Inc., BioSphere Medical Inc., Cepheid; External links 2008-08-06
What's Going On at Roche Palo Alto?: Derek Lowe submits: I've just been told by a reliable source that something big is up with the Roche (RHHBY.PK)-Palo Alto site. I don't know if this is part of their bid for Genentech DNA or what, but the word "closing" has been mentioned. I hate to pass...; Tags: Biotech; External links 2008-08-06
ImClone: Non-Justifiable Scientific Downgrades Refuted: The recent findings of clinical trials on the safety and efficacy of ImClone Systems' IMCL Erbitux in regard to advanced colo-rectal cancer refute the frivolous claim/downgrade by Friedman, Billings Ramsey & Co. analyst Jim Reddoch. The above mentioned analysts, who have absolutely no medical training in evaluating clinical trials, cited...; Tags: Biotech, ImClone Systems Inc.; External links 2008-08-06
Icahn Racks Up Gains in ImClone, Motorola, and Amylin: Lon Juricic submits: Activist investor Carl Icahn had a nice day yesterday. Here's why:Bristol-Myers BMY sent Mr. Icahn a letter presenting a $60 per share offer for ImClone Systems IMCL. Icahn is the Chairman of ImClone, and owns 11,669,544 shares of the biotech company. With shares of ImClone...; Tags: Bristol-Myers Squibb Co., Amylin Pharmaceuticals Inc., Healthcare, Biotech, Gadgets, Motorola Inc., ImClone Systems Inc.; External links 2008-08-01

FDA Delivers Another Blow to Amgen?s Anemic Drug Sales: The Simplified Investor submits: Amgen (NYSE:AMGN) made its reputation as one of the premier firms in the biotechnology industry with its blockbuster anemia drugs, Aranesp and Epogen. Worldwide sales of anemia drugs made up around half of Amgen’s $14.8B revenue in 2007 and an even larger percentage of its...; Tags: Healthcare, Biotech, Amgen Inc.; External links 2008-08-01
Wallstrip: Micrus Endovascular Corp. (MEND): Micrus Endovascular Corp. is in the business of prolonging life, and overseas markets appear to be just what the doctor ordered.; Tags: mi, china, panda, karaoke, david beckham, medicaid, terminator, fda, robocop, borg, star trek, science, rolling stones, bill and ted, family guy, biotech, micrus endovascular corp, mend, nyse, nasdaq, invest, Life, Doctor, Micrus Endovascular Corp., investing, stock stock exchange, stocks, wallstrip, julie alexandria, howard lindzon, india, Business; Videos 2008-07-14
Oral-lyn vs. Afresa: How Generex Will Beat Mannkind: R.J Steffens submits: As biotech companies and large pharma embark on paths to usher in more effective diabetes drugs to market, one of the more significant concerns regarding diabetes related drug development is safety. The FDA has increasingly issued new alerts from previously approved drugs such as GlaxoSmithKline's GSK Avandia,...; Tags: Biotech, Healthcare, R.J Steffens, Generex Biotechnology Corp., MannKind Corp.; External links 2009-11-19
Echo Therapeutics: Positive Developments for a Needle-Free Diabetes Monitoring System: Mike Havrilla submits: Echo Therapeutics (ECTE.OB) is a diabetes management company developing the needle-free Symphony Transdermal Continuous Glucose Monitoring tCGM System as a non-invasive, wireless, transdermal solution for monitoring blood sugar levels and the needle-free Prelude SkinPrep System for transdermal drug delivery applications. On 11/19/09, the Company...; Tags: Biotech, Healthcare, Mike Havrilla; External links 2009-11-19
Expiration Trade Behind Osiris Activity: optionMONSTER submits: By Chris McKhann As we close in on expiration at the end of today's session, traders are rolling out positions that they don't want to be without going into Monday. That's what we are seeing today in Osiris Therapeutics OSIR, where traders are rolling put positions out...; Tags: Biotech, optionMONSTER, Osiris Therapeutics Inc.; External links 2009-11-20
Antigenics, Inc. Q2 2009 Earnings Call Transcript: Antigenics, Inc. AGEN Q2 2009 Earnings Call July 30, 2009 11:00 AM ET; Tags: Biotech, Antigenics Inc.; External links 2009-07-30
Competitive Technologies Issues Another Stunning Press Release: Danny Furman submits: Of the stocks I've written about, Competitive Technologies CTT has performed the worst prior to July 30. The Company owns manufacturing and worldwide distribution rights to a highly effective and demanded pain relief device and reported, in May, guaranteed sales of $25M in 2009 and $50M in...; Tags: Biotech, Danny Furman, Competitive Technologies Inc.; External links 2009-07-30
FDA Calendar Updates: United Therapeutics, Roche: Mike Havrilla submits: Below is a summary of updates to the BioMedReports.com FDA Calendar, which includes a database of 288 entries as of 7/30/09. The calendar was originally created by Mike Havrilla to track companies with pending new drug, biological agent, or medical device new product decisions at the FDA....; Tags: Biotech, Healthcare, Mike Havrilla, United Therapeutics Corp.; External links 2009-07-30
Neurocrine Biosciences, Inc. Q2 2009 Earnings Call Transcript: Neurocrine Biosciences, Inc. NBIX Q2 2009 Earnings Call Transcript July 30, 2009 8:30 am ET; Tags: Biotech, Neurocrine Biosciences Inc.; External links 2009-07-30
AstraZeneca: This Dividend Paying Stock Is Worth Another Look: Capital Preserve submits: AstraZeneca AZN, like many foreign stocks, gets little attention from investors who focus on and write about dividend stocks. This aversion seems to stem from a couple of primary sources. First, foreign dividend payers do not typically pay dividends on a quarterly basis and the...; Tags: Biotech, Healthcare, Capital Preserve, AstraZeneca Plc.; External links 2009-07-30
FDA Calendar Updates: Medivation, Pfizer, AstraZeneca: Mike Havrilla submits: Below is a summary of updates to the BioMedReports.com FDA Calendar, which includes a database of 288 entries as of 7/30/09. The calendar was originally created by Mike Havrilla to track companies with pending new drug, biological agent, or medical device new product decisions at the FDA....; Tags: Biotech, Healthcare, Mike Havrilla, Medivation Inc., Pfizer Inc.; External links 2009-07-30
Rockwell Medical: SFP Is Key to Future Earnings Power: Mike Havrilla submits: Rockwell Medical Technologies (NASDAQ:RMTI) is a small-cap bio-pharmaceutical company with a core, growing business which manufactures, sells, and distributes dialysate which remove toxins and wastes from the blood while replacing nutrients products to patients with chronic kidney disease (CKD) and end-stage renal disease (ESRD) receiving dialysis (which...; Tags: Biotech, Healthcare, Mike Havrilla, Rockwell Medical Technologies Inc.; External links 2009-07-30
Pfizer Underwrites Basic Research at Shanghai Institutes: ChinaBio Today submits: Pfizer (NYSE: PFE) has teamed up with the Shanghai Institutes for Biological Sciences (SIBS) to do basic research. The biggest of pharmas will underwrite $500,000 of health-related basic research projects at SIBS for each of the next three years. Pfizer and SIBS will select the research...; Tags: Biotech, ChinaBio Today, Pfizer Inc.; External links 2009-07-30
AVANIR Pharmaceuticals, Inc. F3Q09 (Qtr End 06/30/09) Earnings Call Transcript: AVANIR Pharmaceuticals, Inc. AVNR F3Q09 (Qtr End 06/30/09) Earnings Call Transcript July 29, 2009 11:00 am ET; Tags: Biotech, Avanir Pharmaceuticals; External links 2009-07-30
Sangamo BioSciences, Inc. Q2 2009 Earnings Call Transcript: Sangamo BioSciences, Inc. SGMO Q2 2009 Earnings Call Transcript July 29, 2009 5:00 pm ET; Tags: Biotech, Sangamo BioSciences Inc.; External links 2009-07-29